First Comparison of Amulet and Watchman FLX LAA Closure Devices

Results from the SWISS-APERO Trial reported at TCT 2021 and published simultaneously in Circulation

Structural Heart Occluders

Left Atrial Appendage (LAA) Occluders

Left Atrial Appendage (LAA) Occluders

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

TCT DAIC

Structural Heart Occluders

Left Atrial Appendage (LAA) Occluders

Diagnostic and Interventional Cardiology

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX Pro Left Atrial Appendage Closure Device

Diagnostic and Interventional Cardiology

Left Atrial Appendage (LAA) Occluders

Cleveland Clinic-Led Trial Finds that Atrial Fibrillation Patients Undergoing TAVR and Watchman Procedures Together Have Similar Outcomes to Using Blood Thinners after TAVR

Diagnostic and Interventional Cardiology

Real-world outcomes from the EU-PORIA registry of the FARAPULSE Pulsed Field Ablation (PFA) System